Patents by Inventor Craig B. Thompson

Craig B. Thompson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6395510
    Abstract: The invention relates generally to compositions of and methods for obtaining and using a polypeptide other than BCL-2 that affects programmed vertebrate cell death. The invention relates as well to polynucleotides encoding those polypeptides, recombinant vectors carrying those sequences, the recombinant host cells including either the sequences or vectors, and recombinant polypeptides. The invention further provides methods for using the isolated, recombinant polypeptides in assays designed to select and improve substances capable of altering programmed cell death for use in diagnostic, drug design and therapeutic applications.
    Type: Grant
    Filed: March 17, 1999
    Date of Patent: May 28, 2002
    Assignees: ARCH Development Corporation, Board of Regents of The University of Michigan
    Inventors: Craig B. Thompson, Lawrence H. Boise, Gabriel Nuñez
  • Patent number: 6352694
    Abstract: Methods for inducing a population of T cells to proliferate by activating the population of T cells and stimulating an accessory molecule on the surface of the T cells with a ligand which binds the accessory molecule are described. T cell proliferation occurs in the absence of exogenous growth factors or accessory cells. T cell activation is accomplished by stimulating the T cell receptor (TCR)/CD3 complex or the CD2 surface protein. To induce proliferation of an activated population T cells, an accessory molecule on the surface of the T cells, such as CD28, is stimulated with a ligand which binds the accessory molecule. The T cell population expanded by the method of the invention can be genetically transduced and used for immunotherapy or can be used in methods of diagnosis.
    Type: Grant
    Filed: March 10, 1995
    Date of Patent: March 5, 2002
    Assignees: Genetics Institute, Inc., The Regents of the University of Michigan
    Inventors: Carl H. June, Craig B. Thompson, Gary J. Nabel, Gary S. Gray, Paul D. Rennert
  • Publication number: 20010053361
    Abstract: A method of immunotherapy stimulates the T cell CD28 surface molecule to enhance T cell proliferation and increase overall lymphokine levels or to increase cellular production of human TH1 lymphokines or both. Thee method is selective for the induction of activated T cell mediated immune responses and enhances immune function even in the presence of immunosuppresants.
    Type: Application
    Filed: June 7, 1995
    Publication date: December 20, 2001
    Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: CRAIG B. THOMPSON, CARL H. JUNE, JEFFREY A. LEDBETTER, TULLIA LINDSTEN
  • Patent number: 6316600
    Abstract: The present invention provides methods for producing antibodies against a variety of antigens, including mammalian antigens with highly conserved epitopes. In addition, the present invention provides improved methods and compositions for the cloning and manipulation of immunoglobulin genes as well as antibodies derived therefrom.
    Type: Grant
    Filed: August 6, 1997
    Date of Patent: November 13, 2001
    Assignee: Arch Development Corporation
    Inventors: Nancy M. Michael, Mary Ann V Accavitti, Craig B. Thompson
  • Patent number: 6303331
    Abstract: The invention relates generally to compositions of and methods for obtaining and using a polypeptide other than BCL-2 that affects programmed vertebrate cell death. The invention relates as well to polynucleotides encoding those polypeptides, recombinant vectors carrying those sequences, the recombinant host cells including either the sequences or vectors, and recombinant polypeptides. The invention further provides methods for using the isolated, recombinant polypeptides in assays designed to select and improve substances capable of altering programmed cell death for use in diagnostic, drug design and therapeutic applications.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: October 16, 2001
    Assignees: Arch Development Corporation, The Regent of the University of Michigan
    Inventors: Craig B. Thompson, Lawrence H. Boise, Gabriel Nuñez
  • Patent number: 6143559
    Abstract: The present invention provides methods for producing antibodies against a variety of antigens, including mammalian antigens with highly conserved epitopes. In addition, the present invention provides improved methods and compositions for the cloning and manipulation of immunoglobulin genes as well as antibodies derived therefrom.
    Type: Grant
    Filed: November 18, 1996
    Date of Patent: November 7, 2000
    Assignee: Arch Development Corporation
    Inventors: Nancy M. Michael, Mary Ann Accavitti, Craig B. Thompson
  • Patent number: 6143291
    Abstract: Methods for protecting a T cell from cell death are described. The methods involve contacting the T cell with an agent which augments the bcl-X.sub.L protein level in the T cell such that it is protected from cell death. The invention further pertains to methods for increasing the susceptibility of a T cell to cell death, comprising contacting the T cell with at least one agent which decreases bcl-X.sub.L protein level in the T cell. Both in vivo and in vitro methods are described.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: November 7, 2000
    Inventors: Carl H. June, Craig B. Thompson
  • Patent number: 5858358
    Abstract: Methods for inducing a population of T cells to proliferate by activating the population of T cells and stimulating an accessory molecule on the surface of the T cells with a ligand which binds the accessory molecule are described. T cell proliferation occurs in the absence of exogenous growth factors or accessory cells. T cell activation is accomplished by stimulating the T cell receptor (TCR)/CD3 complex or the CD2 surface protein. To induce proliferation of an activated population T cells, an accessory molecule on the surface of the T cells, such as CD28 or CD9, is stimulated with a ligand which binds the accessory molecule. The T cell population expanded by the method of the invention can be genetically transduced and used for immunotherapy or can be used in methods of diagnosis.
    Type: Grant
    Filed: June 3, 1994
    Date of Patent: January 12, 1999
    Assignees: The United States of America as represented by the Secretary of the Navy, The Regents of the University of Michigan, Dana-Farber Cancer Institute
    Inventors: Carl H. June, Craig B. Thompson, Gary J. Nabel, Gary S. Gray, Paul D. Rennert, Gordon J. Freeman
  • Patent number: 5834309
    Abstract: The invention relates generally to compositions of and methods for obtaining and using a polypeptide other than BCL-2 that affects programmed vertebrate cell death. The invention relates as well to polynucleotides encoding those polypeptides, recombinant vectors carrying those sequences, the recombinant host cells including either the sequences or vectors, and recombinant polypeptides. The invention further provides methods for using the isolated, recombinant polypeptides in assays designed to select and improve substances capable of altering programmed cell death for use in diagnostic, drug design and therapeutic applications.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: November 10, 1998
    Assignee: Arch Development Corporation
    Inventors: Craig B. Thompson, Lawrence H. Boise, Gabriel Nunez
  • Patent number: 5646008
    Abstract: The invention relates generally to compositions of and methods for obtaining and using a polypeptide other than BCL-2 that affects programmed vertebrate cell death. The invention relates as well to polynucleotides encoding those polypeptides, recombinant vectors carrying those sequences, the recombinant host cells including either the sequences or vectors, and recombinant polypeptides. The invention further provides methods for using the isolated, recombinant polypeptides in assays designed to select and improve substances capable of altering programmed cell death for use in diagnostic, drug design and therapeutic applications.
    Type: Grant
    Filed: June 22, 1993
    Date of Patent: July 8, 1997
    Assignee: The Regent of the University of Michigan
    Inventors: Craig B. Thompson, Lawrence H. Boise, Gabriel Nunez
  • Patent number: 5616491
    Abstract: Mice lacking expression of CD28 or particular CD45 isoforms in certain cells of the immune system are provided. Also provided are methods of using these mice.
    Type: Grant
    Filed: September 14, 1995
    Date of Patent: April 1, 1997
    Assignees: Ontario Cancer Institute, Craig B. Thompson
    Inventors: Tak W. Mak, Craig B. Thompson
  • Patent number: 4273791
    Abstract: A process for making fried taco shells. Disc tortillas are formed from a sheet of ground corn masa dough, and the formed disc tortillas are passed laterally through a heated baking oven on laterally moving open web support means in successive, appreciably longitudinally spaced transverse rows, each such row including a plurality of the tortillas. The baked tortillas are transferred in the aforesaid row arrangement through an elongated steam chamber and exposed to low pressure steam in the chamber for a time period of about a few seconds to about a few minutes. The steam exposure effects tempering and moisture equilibration in the tortillas. The tempered tortillas are transferred into and through deep fat frying apparatus.
    Type: Grant
    Filed: October 26, 1979
    Date of Patent: June 16, 1981
    Assignee: Heublein, Inc.
    Inventors: Sheldon H. Hanson, Craig B. Thompson, James E. Olson
  • Patent number: 4197793
    Abstract: Taco shell manufacturing equipment that comprises in combination with suitable means to form and bake disk tortillas, certain means to equilibrate moisture throughout such baked tortillas in a relatively short tempering time of the general order of a few minutes as they are passed in successive longitudinally-spaced groups of substantially transversely aligned disks continuously through an elongated lateral steam chamber upon traveling lateral open web belting means as received from baking means and while being subjected in this chamber to relatively low pressure steam until discharged by this belting means through an exit end opening of the steam chamber as tempered tortillas. Driven lateral transfer means receive the tempered tortillas in the longitudinally-spaced transverse groups from the exit end of the steam chamber and transports them laterally forward to the entrance end of tortillas folding and frying apparatus.
    Type: Grant
    Filed: August 8, 1977
    Date of Patent: April 15, 1980
    Assignee: Heublein, Inc.
    Inventors: Sheldon H. Hanson, Craig B. Thompson, James E. Olson